Apel Daniel Joseph bought ARWR
January 6, 2026 · Form 4 insider transaction
Apel Daniel Joseph bought 75,000 shares of Arrowhead Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
75,000
Price
$0.00
Total value
N/A
InsiderApel Daniel Joseph
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 6, 2026
Filing dateJanuary 8, 2026
Shares owned after176,200
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares underlying restricted stock units which will vest in four equal annual installments.; Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.